Tags:EquipmentHardwareInformationManagementManufacturingMedTechProductSupplyTraining
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 100,000 implanted to date. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.
Likes
989
Location: United States, Ohio, Mason
Member count: 501-1000
Phone: +1 513-755-4100
Founded date: 2000

Investors 1

Mentions in press and media 59

DateTitleDescriptionCategoryAuthorSource
29.09.2022Analysts h...[Image from AtriCure]Analysts ...-Sean Whool...massdevice...
16.02.2022AtriCure p...AtriCure (NASDAQ:ATRC) this mo...-Danielle K...massdevice...
03.11.2021AtriCure R...AtriCure Reports Third Quarter...--marketscre...
13.08.2019AtriCure t...AtriCure, Inc.(NASDAQ:ATRC), a...USA-finsmes.co...
15.09.2016ReFlow The... Early July this year, renown...Financing-startuptic...
13.04.2016Morning Re...Atrial fibrillation treatment ...--medcitynew...
31.01.2014AtriCure C...WEST CHESTER, Ohio—(BUSINESS W...News-thpartners...
30.10.2013AtriCure g...AtriCure (NSDQ:ATRC) shares ad...-Brad Perri...massdevice...
03.05.2012AtriCure s...AtriCure (NSDQ:ATRC) shares ga...-MassDevice...massdevice...
13.04.2012AtriCure C...Drachman’s salary in 2010 was ...--medcitynew...
Show more